NSC337766

dc.creatorUS National Cancer Institute
dc.date2006-05-04T11:56:12Z
dc.date2006-05-04T11:56:12Z
dc.date2003-02-01
dc.date2006-05-04T11:56:12Z
dc.date.accessioned2026-08-03T04:19:22Z
dc.format8429 bytes
dc.format7072 bytes
dc.formatchemical/x-cml
dc.formatchemical/x-cml
dc.formatchemical/x-cml
dc.formatchemical/x-cml
dc.identifierNSC337766
dc.identifierhttp://www.dspace.cam.ac.uk/handle/1810/171966
dc.identifierNJSMWLQOCQIOPE-OCHFTUDZSA-N
dc.identifierInChI=1S/C22H22N8/c1-2-6-16-15(5-1)19(13-27-29-21-23-9-10-24-21)17-7-3-4-8-18(17)20(16)14-28-30-22-25-11-12-26-22/h1-8,13-14H,9-12H2,(H2,23,24,29)(H2,25,26,30)/b27-13+,28-14+
dc.identifierC22H22N8,1H-2H-6H-16-15(5H-1)19(9H-23-29H-21-25-11H2-13H2-27H-21)17-7H-3H-4H-8H-18(17)20(16)10H-24-30H-22-26-12H2-14H2-28H-22
dc.identifier.urihttps://repo.dare.co.zw/handle/123456789/187820
dc.languageen_GB
dc.publisherUnilever Center for Molecular Informatics, Cambridge University
dc.titleNSC337766
dc.titleBisantrene hydrochloride (USAN)
dc.titleCL 216942
dc.titleNSC 337766
dc.title9, 10-Anthracenedicarboxaldehyde, bis(4, 5-dihydro-1H-imidazol-2-ylhydrazone),dihydrochloride (9CI)
dc.title9, 10-Anthracenedicarboxaldehyde, bis[(4, 5-dihydro-1H-imidazol-2-yl)hydrazone], dihydrochloride
dc.typeChemical Structures

Files